Article
Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes.
Internal medicine (Tokyo, Japan) - 1 Jan 2021
Nakajima Hideaki
Abstract excerpt
Myelodysplastic syndromes (MDS) are clonal hematological disorders arising from hematopoietic stem cells that have accumulated various genetic abnormalities. MDS are heterogeneous in nature but uniformly characterized by chronic and progressive cytopenia from ineffective hematopoiesis, dysplasia in single or multiple lineages, and transformation to acute leukemia in a subset of patients. The genomic landscape...
Topics
- DNA Methylation
- Humans
- Leukemia, Myeloid, Acute
- Mutation
- Myelodysplastic Syndromes
- RNA Splicing
